stoxline Quote Chart Rank Option Currency Glossary
  
AnPac Bio-Medical Science Co., Ltd. (ANPC)
4.3  -0.14 (-3.15%)    05-19 15:59
Open: 4.57
High: 4.63
Volume: 35,704
  
Pre. Close: 4.44
Low: 4.25
Market Cap: 27(M)
Technical analysis
2023-08-04 4:26:32 PM
Short term     
Mid term     
Targets 6-month :  4.67 1-year :  5.19
Resists First :  4 Second :  4.44
Pivot price 4.04
Supports First :  3.27 Second :  2.72
MAs MA(5) :  3.98 MA(20) :  4.06
MA(100) :  5.21 MA(250) :  5.18
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  41.4 D(3) :  45.6
RSI RSI(14): 42.1
52-week High :  11.98 Low :  2.59
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ANPC ] has closed above bottom band by 4.3%. Bollinger Bands are 77.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 41 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 4.1 - 4.13 4.13 - 4.15
Low: 3.74 - 3.77 3.77 - 3.79
Close: 3.76 - 3.8 3.8 - 3.84
Company Description

AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.

Headline News

Wed, 14 Dec 2022
What Was The Reason Behind AnPac Bio-Medical (ANPC) Stock Increasing In The Extended Session? – State Reviewer - State Reviewer

Mon, 11 Apr 2022
Popular Penny Stocks to Buy in April? 3 to Watch Right Now - Penny Stocks

Fri, 08 Apr 2022
AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) Receive Letter From the Nasdaq Stock Department on Potential ... - BP Journal

Mon, 21 Mar 2022
Nasdaq Listing Issues Anpac Bio-Medical Sciences Co Ltd (NASDAQ: ANPC) With a Written of the Company's Breaches - BP Journal

Wed, 16 Mar 2022
Best Penny Stocks To Buy? 5 China Stocks To Watch Right Now - Penny Stocks

Mon, 24 Jan 2022
AnPac Bio Receives NASDAQ Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 6 (M)
Shares Float 6 (M)
Held by Insiders 2.1 (%)
Held by Institutions 0.1 (%)
Shares Short 44 (K)
Shares Short P.Month 28 (K)
Stock Financials
EPS -11.45
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 10.63
Profit Margin 0 %
Operating Margin -871.2 %
Return on Assets (ttm) -52.7 %
Return on Equity (ttm) -243.2 %
Qtrly Rev. Growth -70 %
Gross Profit (p.s.) 0
Sales Per Share 1.7
EBITDA (p.s.) -14.04
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio -0.34
PEG Ratio 0
Price to Book value 0.35
Price to Sales 2.23
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android